Severe thrombocytopenia and excellent response following combined immune checkpoint inhibition for metastatic malignant melanoma

J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e89-e92. doi: 10.1111/jdv.16829. Epub 2020 Aug 11.

Authors

R Wang¹, M Uretzki¹, D Boehmer¹, R Hein¹, T Biedermann¹, C Posch¹

Affiliation

¹ Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany.

PMID: 32701189
DOI: 10.1111/jdv.16829

No abstract available

Publication types

Letter

MeSH terms

Humans
Immune Checkpoint Inhibitors
Immunotherapy
Ipilimumab / therapeutic use
Melanoma* / drug therapy
Thrombocytopenia* / chemically induced

Substances

Immune Checkpoint Inhibitors
Ipilimumab